Skip to content

Open-label study of BBO-11818 in adult subjects with KRAS mutant cancer

Status
Not yet recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2025-524690-16-00
Enrollment
999999
Registered
2026-06-16
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Solid Tumors

Interventions

None listed

Sponsors

Theras Inc.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Outcome results

None listed

Source: EU CTIS · Data processed: Jun 17, 2026